Flinton Capital Management’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $215K | Buy |
4,112
+320
| +8% | +$16.7K | 0.01% | 654 |
|
|
2019
Q2 | $183K | Buy |
3,792
+48
| +1% | +$2.32K | 0.01% | 696 |
|
|
2019
Q1 | $189K | Hold |
3,744
| – | – | 0.01% | 683 |
|
|
2018
Q4 | $222K | Buy |
3,744
+16
| +0.4% | +$949 | 0.01% | 628 |
|
|
2018
Q3 | $245K | Buy |
3,728
+16
| +0.4% | +$1.05K | 0.01% | 668 |
|
|
2018
Q2 | $187K | Hold |
3,712
| – | – | 0.01% | 673 |
|
|
2018
Q1 | $195K | Buy |
3,712
+464
| +14% | +$24.4K | 0.01% | 657 |
|
|
2017
Q4 | $151K | Buy |
3,248
+560
| +21% | +$26K | 0.01% | 707 |
|
|
2017
Q3 | $109K | Buy |
2,688
+752
| +39% | +$30.5K | ﹤0.01% | 726 |
|
|
2017
Q2 | $66K | Buy |
1,936
+976
| +102% | +$33.3K | ﹤0.01% | 773 |
|
|
2017
Q1 | $28K | Sell |
960
-928
| -49% | -$27.1K | ﹤0.01% | 804 |
|
|
2016
Q4 | $62K | Buy |
+1,888
| New | +$62K | ﹤0.01% | 684 |
|